Ads

 

Ads

 

Ads

 

Top Healthcare Companies in UK List by Market Cap as on July-30-2023

Top Healthcare Companies in UK List by Market Cap as on July-30-2023. Biggest and Top Healthcare Companies in UK Companies by Market Cap. Largest Top Healthcare Companies in UK List by Market Cap as on July-30-2023.
Metatag Title
Top Healthcare Companies in UK
Metatag Abstract
Top Healthcare Companies in UK, Biggest Healthcare Companies in UK, Largest Healthcare Companies in UK.
  1. AstraZeneca

    World Rank (Jan-05-2024)
    48
    Market Cap (Jan-05-2024)
    213.330 Billion USD
    World Rank (Jul-30-2023)
    44
    Market Cap (Jul-30-2023)
    221.350 Billion USD
    World Rank (Dec-25-2022)
    40
    Market Cap (Dec-25-2022)
    210.670 Billion USD
    World Rank (Jan-07-2022)
    71
    Market Cap (Jan-07-2022)
    178.12 Billion USD
    Annual Revenue in USD
    45,811 Million USD
    Annual Net Income in USD
    5,955 Million USD
    Annual Results for Period Ending
    Dec-2023 ending year
    Headquarters Country
    Company Profile

    AstraZeneca is UK Based Pharmaceutical and Bio-Technology Company. They have done some advanced research on Oncology. In the fight against COVID-19, AstraZeneca is one among World Top 5 Companies which has done advanced phase of Covid-19 testing in collaboration with the University of Oxford. Headquarters is in UK.

    AstraZeneca Product Sales of 43,789 million USD split by Disease Area for year ending Dec-2023

    Facts About Company

    For year ending Dec-2023, AstraZeneca annual Total revenue was 45,811 million USD and annual operating profit was 8,193 million USD and annual net income was 5,961 million USD.

    AstraZeneca annual revenue was 44,351 million USD for year ending Dec-2022 and annual operating profit was 3,757 million USD and annual net income was 3,293 million USD for year ending Dec-2022.

    AstraZeneca has 89,900 employees as of 2023. 

  2. GSK plc

    World Rank (Jan-05-2024)
    179
    Market Cap (Jan-05-2024)
    80.265 Billion USD
    World Rank (Jul-30-2023)
    212
    Market Cap (Jul-30-2023)
    72.563 Billion USD
    World Rank (Dec-25-2022)
    185
    Market Cap (Dec-25-2022)
    72.099 Billion USD
    World Rank (Jan-07-2022)
    132
    Market Cap (Jan-07-2022)
    110.32 Billion USD
    Annual Revenue in USD
    37,666 Million USD
    Annual Operating Income in USD
    8,263 Million USD
    Annual Net Income in USD
    19,211 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    GLAXOSMITHKLINE is UK based multi-national Pharmaceuticals business and it has a broad portfolio of innovative and established medicines. GSK currently focus on developing new medicines in respiratory, HIV, oncology and immuno-inflammation; with an R&D approach focused on science related to the immune system, use of genetics and advanced technologies. Headquarters is in UK.

    In 2021 GSK delivered 1.7 billion medicines, over 767 million vaccines* and 3.7 billion consumer healthcare products.

    Facts About Company

    GSK annual revenue was 29,324 Million GBP and annual net income was 14,956 Million GBP for year ending Dec-2022.

    GSK annual revenues for year ending Dec-2021 was 34,144 million GBP and annual operating income was 6,165 million GBP and annual net income of 4,385 million GBP.

    GSK had 70,000 employees as on 2022.

    As on 2021, GSK has over 90,000 employees across 92 countries and work directly with 37,500 suppliers.

  3. Smith & Nephew

    World Rank (Jan-05-2024)
    1,434
    Market Cap (Jan-05-2024)
    11.933 Billion USD
    World Rank (Jul-30-2023)
    1,311
    Market Cap (Jul-30-2023)
    13.398 Billion USD
    World Rank (Dec-25-2022)
    1,349
    Market Cap (Dec-25-2022)
    11.698 Billion USD
    World Rank (Jan-07-2022)
    1,290
    Market Cap (Jan-07-2022)
    15.69 Billion USD
    Annual Revenue in USD
    5,215 Million USD
    Annual Operating Income in USD
    450 Million USD
    Annual Net Income in USD
    223 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Medical Equipment manufacturing company with headquarters is in London, UK.

    Smith & Nephew design and manufacture technology that takes the limits off living and support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential.

    Smith & Nephew operates on a worldwide basis and has distribution channels in over 100 countries.

    Smith & Nephew serve customers through their three global franchises.

    Facts About Company

    Smith & Nephew annual revenue generated for period ending Dec-2022 was 5,215 million USD and annual net income was 223 million USD.

    Smith & Nephew annual revenue generated for period ending Dec-2021 was 5,212 million USD and annual net income was 524 million USD.

    As on 2022, Smith & Nephew had 17,500 employees.

  4. Hikma Pharmaceuticals

    World Rank (Jan-05-2024)
    2,843
    Market Cap (Jan-05-2024)
    5.182 Billion USD
    World Rank (Jul-30-2023)
    2,549
    Market Cap (Jul-30-2023)
    5.954 Billion USD
    World Rank (Dec-25-2022)
    3,183
    Market Cap (Dec-25-2022)
    4.138 Billion USD
    World Rank (Jan-07-2022)
    2,587
    Market Cap (Jan-07-2022)
    6.71 Billion USD
    Annual Revenue in USD
    3,233 Million USD
    Annual Operating Income in USD
    619 Million USD
    Annual Net Income in USD
    241 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Hikma Pharmaceuticals is a pharmaceutical company. It develop, manufacture and market nearly 700 quality branded and non branded generic medicines worldwide. The company categories include anti infectives, cardiovascular, central nervous system, diabetes, oncology, pain management and respiratory. The headquarters is in UK.

    Facts About Company

    HIKMA PHARMACEUTICALS annual revenue was 2,517 million GBP and annual net income was 188 million GBP generated for period year ending Dec-2022.

    HIKMA PHARMACEUTICALS annual revenue was 2,553 million GBP and annual net loss was 421 million GBP generated for period year ending Dec-2021.

    As on 2022, HIKMA PHARMACEUTICALS had 8800 employees.

  5. Convatec Group

    World Rank (Jan-05-2024)
    2,433
    Market Cap (Jan-05-2024)
    6.341 Billion USD
    World Rank (Jul-30-2023)
    2,737
    Market Cap (Jul-30-2023)
    5.491 Billion USD
    World Rank (Dec-25-2022)
    2,433
    Market Cap (Dec-25-2022)
    5.726 Billion USD
    World Rank (Jan-07-2022)
    3,166
    Market Cap (Jan-07-2022)
    5.23 Billion USD
    Annual Revenue in USD
    2,072 Million USD
    Annual Operating Income in USD
    221 Million USD
    Annual Net Income in USD
    63 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    ConvaTec Group is a Medical Products and Technologies Company. It products provide a range of clinical and economic benefits including infection prevention, protection of at risk skin, improved patient outcomes and reduced total cost of care. It is having 9,400 employees and business in more than 110 countries. The headquarters is in UK.

    Facts About Company

    ConvaTec Group annual revenue was 2,072 million GBP and annual net income was 62 million GBP generated for period year ending Dec-2022.

    ConvaTec Group annual revenue was 2,038 million GBP and annual net income was 117 million GBP generated for period year ending Dec-2021.

    As on 2022, ConvaTec Group had 10000 employees.

  6. Dechra Pharmaceuticals

    World Rank (Jan-05-2024)
    2,696
    Market Cap (Jan-05-2024)
    5.566 Billion USD
    World Rank (Jul-30-2023)
    2,759
    Market Cap (Jul-30-2023)
    5.433 Billion USD
    World Rank (Dec-25-2022)
    3,556
    Market Cap (Dec-25-2022)
    3.614 Billion USD
    World Rank (Jan-07-2022)
    2,623
    Market Cap (Jan-07-2022)
    6.58 Billion USD
    Annual Revenue in USD
    963 Million USD
    Annual Operating Income in USD
    8 Million USD
    Annual Net Income in USD
    -34 Million USD
    Annual Results for Period Ending
    Jun-2023 ending period
    Headquarters Country
    Stock Category
    Company Profile

    Dechra Pharmaceuticals is a specialist Veterinary Pharmaceuticals and related products business. It expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. The headquarters is in UK.

    Facts About Company

    Dechra Pharmaceuticals annual revenue was 681 million GBP and annual net income was 58 million GBP generated for period year ending Jun-2022.

    Dechra Pharmaceuticals annual revenue was 608 million GBP and annual net income was 55 million GBP generated for period year ending Jun-2021.

    As on 2023, Dechra Pharmaceuticals had 2400 employees.

  7. Abcam

    World Rank (Jan-05-2024)
    2,771
    World Rank (Jul-30-2023)
    2,771
    Market Cap (Jul-30-2023)
    5.396 Billion USD
    World Rank (Dec-25-2022)
    3,615
    Market Cap (Dec-25-2022)
    3.542 Billion USD
    World Rank (Jan-07-2022)
    3,422
    Market Cap (Jan-07-2022)
    4.75 Billion USD
    Annual Revenue in USD
    457 Million USD
    Annual Operating Income in USD
    -13 Million USD
    Annual Net Income in USD
    -10 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile

    Abcam is a Biological Reagents company. It is essential in a wide range of fields and applications including drug discovery, diagnostics and basic research and present across eleven sites globally. The headquarters is in UK.

    Abcam is the leading Supplier of Protein Research Tools to Life Scientists company. The company annual revenue is 316.8 million USD and 1,492 employees as on 2019.

    Danaher has acquired Abcam for 5.7 billion USD in 2023.

    Facts About Company

    Abcam annual revenue was 361 million GBP and annual net loss was -8 million GBP generated for period year ending Dec-2022.

    Abcam annual revenue was 315 million GBP and annual net income was 4 million GBP generated for period year ending Dec-2021.

    As on 2022, Abcam had 1760 employees.

  8. GW Pharmaceuticals

    World Rank (Jan-05-2024)
    3,962
    World Rank (Jul-30-2023)
    3,962
    World Rank (Dec-25-2022)
    3,962
    World Rank (Jan-07-2022)
    3,962
    Annual Revenue in USD
    527 Million USD
    Annual Net Income in USD
    -58 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile

    GW Pharmaceuticals is a position in the development of plant derived cannabinoid therapeutics through it proven drug discovery and development processes intellectual property portfolio and regulatory and manufacturing expertise. The headquarters is in UK.

  9. LivaNova

    World Rank (Jan-05-2024)
    4,732
    Market Cap (Jan-05-2024)
    2.683 Billion USD
    World Rank (Jul-30-2023)
    4,247
    Market Cap (Jul-30-2023)
    3.108 Billion USD
    World Rank (Dec-25-2022)
    4,217
    Market Cap (Dec-25-2022)
    2.874 Billion USD
    World Rank (Jan-07-2022)
    3,621
    Market Cap (Jan-07-2022)
    4.40 Billion USD
    Annual Revenue in USD
    1,035 Million USD
    Annual Net Income in USD
    -135 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    LivaNova is a Medical Technology company. The company products and therapies are neuromodulation, resources and cardiovascular. It offers a diverse product portfolio with a differentiated pipeline and reach is broad with a presence in more than 100 countries and approximately 4,000 employees. The headquarters is in UK.

  10. Myovant Sciences

    World Rank (Jan-05-2024)
    4,776
    World Rank (Jul-30-2023)
    4,776
    Market Cap (Jul-30-2023)
    2.620 Billion USD
    World Rank (Dec-25-2022)
    4,545
    Market Cap (Dec-25-2022)
    2.608 Billion USD
    World Rank (Jan-07-2022)
    8,121
    Market Cap (Jan-07-2022)
    1.29 Billion USD
    Annual Revenue in USD
    271 Million USD
    Annual Net Income in USD
    -241 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Company Profile

    Myovant Sciences is a biopharmaceutical company. It works for women and for men through purpose driven science, Empowering Medicines and Transformative Advocacy company. It have three clinical programs for relugolix which consisted of five international phase 3 clinical trials, two in women with heavy menstrual bleeding associated with uterine fibroids, two in women with endometriosis associated pain and one in men with advanced prostate cancer. The headquarters is in UK.

    Sumitovant Biopharma acquired Myovant Sciences for 1.7 billion USD in 2023.

Share

Ads